Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
A Phase 1B Study of KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Acute Myeloid Leukemia
Sponsor: National Cancer Institute (NCI)
This PHASE1 trial investigates Acute Myeloid Leukemia and Recurrent Acute Myeloid Leukemia and is currently ongoing. National Cancer Institute (NCI) leads this study, which shows 58 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
58 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE1
-
Feb 2026 — Mar 2026 [monthly]
Active Not Recruiting PHASE1
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1
-
Mar 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1
▶ Show 53 earlier versions
-
Oct 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE1
Status: Suspended → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE1
-
Mar 2024 — Jun 2024 [monthly]
Recruiting PHASE1
-
Feb 2024 — Mar 2024 [monthly]
Recruiting PHASE1
-
Dec 2023 — Feb 2024 [monthly]
Recruiting PHASE1
-
Oct 2023 — Dec 2023 [monthly]
Recruiting PHASE1
-
Sep 2023 — Oct 2023 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
Mar 2023 — Sep 2023 [monthly]
Suspended PHASE1
-
Sep 2022 — Mar 2023 [monthly]
Suspended PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Suspended PHASE1
-
Mar 2022 — Jul 2022 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE1
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE1
-
Oct 2021 — Dec 2021 [monthly]
Recruiting PHASE1
-
Jun 2021 — Oct 2021 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
May 2021 — Jun 2021 [monthly]
Suspended PHASE1
-
Apr 2021 — May 2021 [monthly]
Suspended PHASE1
-
Feb 2021 — Apr 2021 [monthly]
Suspended PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Suspended PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE1
-
Jun 2020 — Oct 2020 [monthly]
Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE1
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Sep 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Suspended PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Nov 2018 — Mar 2019 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
Mar 2018 — May 2018 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Jan 2018 — Mar 2018 [monthly]
Recruiting PHASE1
-
Dec 2017 — Jan 2018 [monthly]
Recruiting PHASE1
-
Nov 2017 — Dec 2017 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE1
-
May 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .